Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$0.61 - $2.21 $11,929 - $43,218
-19,556 Closed
0 $0
Q2 2018

Sep 27, 2018

SELL
$1.56 - $2.51 $395,399 - $636,187
-253,461 Reduced 92.84%
19,556 $31,000
Q2 2018

Aug 10, 2018

BUY
$1.56 - $2.51 $395,399 - $636,187
253,461 Added 1296.08%
273,017 $22.4 Million
Q1 2018

May 14, 2018

BUY
$0.91 - $2.24 $17,795 - $43,805
19,556 New
19,556 $42,000

Others Institutions Holding DRRX

About DURECT CORP


  • Ticker DRRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 227,794,000
  • Market Cap $221M
  • Description
  • DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...
More about DRRX
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.